Allogeneic CAR-T cell therapy is produced using CRISPR gene editing from cells donated by healthy individuals.

Intellia’s stock fell 23% after one patient in its Phase III MAGNITUDE trial developed severe liver toxicity that later ...

Fetal bovine serum (FBS) has long served as a foundational input for cell culture, tissue engineering, and biomanufacturing.

The IDMO Smart Factory initiative has the potential to help advance the development and approval of CAR-T therapeutics in ...

A decades-old TB vaccine turned cancer therapy may unlock new immunotherapies by reprogramming immune cell development in the ...

Mouse models treated with the sleep aid lemborexant had less brain damage compared to controls and mice that received a ...